Piramal Critical Care, Inc (PCC), a global hospital generics business and a subsidiary of Piramal Pharma Limited, has entered into a collaboration with Blue-Zone Technologies Ltd to advance a full-lifecycle solution for capturing and recycling waste anaesthetic gases used in clinical settings. The partnership brings together Blue-Zone’s proprietary technology for capturing, collecting, and processing waste anaesthetic gases with Piramal Critical Care’s global manufacturing and commercial capabilities. The initiative is designed to help healthcare providers reduce the environmental footprint of volatile anaesthetics while preserving access to inhaled agents that remain central to modern surgical care.
Subject to regulatory clearance in Europe, Blue-Zone’s Phoenix Deltasorb® waste anaesthetic gas capture system will be made available to PCC customers, beginning with deployments in France and Germany. Blue-Zone will manage the installation, supply, and operational use of the systems within healthcare facilities.
Captured waste anaesthetic gas will be processed by PCC using Blue-Zone’s technology to produce Sevoflurane USP for human use at Piramal Critical Care’s facility in Canada. The companies expect to expand both the recycling program and the marketing of recycled Sevoflurane USP into additional regions over time.
The collaboration supports hospitals in balancing clinical effectiveness with sustainability goals, enabling clinicians to continue using inhaled anaesthetics best suited to patient needs while reducing environmental impact. It also contributes to broader healthcare efforts to manage emissions associated with anaesthesia without compromising patient care.
Blue-Zone is an Ontario-based cleantech pharmaceutical company pioneering the capture, recovery, and processing of waste anaesthetic gas (WAG). Our mission is to protect the environment while enabling the sustainable production of volatile anaesthetics.
Backed by strategic investors and experienced leadership, Blue-Zone brings together a dedicated team, approved anaesthetic drugs in Canada, and a global network of business and technology partners. We design and commercialize integrated equipment and processes that support the full life cycle of volatile anaesthetics—from collection at healthcare facilities to the conversion of recovered WAG into approved anaesthetic medications.
Piramal Critical Care operates a global manufacturing and supply network serving hospitals in more than 100 countries. Its portfolio includes inhaled anaesthetics, intrathecal therapies, plasma volume expanders, and injectable generics, produced at GMP-compliant facilities in the United States and India.